Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial.
about
Pregabalin for acute and chronic pain in adultsEvidence-based guideline: Treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and RehabilitatiPharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain SocietyManagement of men diagnosed with chronic prostatitis/chronic pelvic pain syndrome who have failed traditional managementRoad map for pain management in pancreatic cancer: A reviewThe Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic PotentialPregabalin attenuates excitotoxicity in diabetesThe effectiveness of anticonvulsants in psychiatric disordersGuidelines in the management of diabetic nerve pain: clinical utility of pregabalin.Treatment patterns of postherpetic neuralgia patients before and after the launch of pregabalin and its effect on medical costs: Analysis of Japanese claims data provided by Japan Medical Data Center.Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: a double-blind placebo-controlled trial.Treatment of diabetic sensory polyneuropathy.Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain.Diabetic neuropathy: mechanisms to managementThe management of diabetic neuropathy in CKD.Treating Diabetic Neuropathy: Present Strategies and Emerging Solutions.Efficacy and safety evaluation of pregabalin treatment over 52 weeks in patients with diabetic neuropathic pain extended after a double-blind placebo-controlled trial.Pregabalin for painful HIV neuropathy: a randomized, double-blind, placebo-controlled trial.Evaluation of the safety and efficacy of pregabalin in older patients with neuropathic pain: results from a pooled analysis of 11 clinical studiesTreatment considerations for elderly and frail patients with neuropathic painA cost-consequences analysis of the effect of pregabalin in the treatment of peripheral neuropathic pain in routine medical practice in primary care settings.Topiramate improves neurovascular function, epidermal nerve fiber morphology, and metabolism in patients with type 2 diabetes mellitus.Evidence-based guideline: treatment of painful diabetic neuropathy--report of the American Association of Neuromuscular and Electrodiagnostic Medicine, the American Academy of Neurology, and the American Academy of Physical Medicine & RehabilitationDiabetic neuropathy part 1: overview and symmetric phenotypesPatient-reported-outcomes in subjects with painful lumbar or cervical radiculopathy treated with pregabalin: evidence from medical practice in primary care settings.Characteristics of neuropathic pain in patients with spinal cord injury.Integrating data from randomized controlled trials and observational studies to predict the response to pregabalin in patients with painful diabetic peripheral neuropathy.Pregabalin: latest safety evidence and clinical implications for the management of neuropathic pain.A2delta ligands gabapentin and pregabalin: future implications in daily clinical practice.Pharmacologic therapies for complex regional pain syndrome.Cough pharmacotherapy: current and future status.A psychopharmacological treatment algorithm for generalised anxiety disorder (GAD)Diabetic neuropathy: clinical manifestations and current treatments.Pregabalin treatment for peripheral neuropathic pain: a review of safety data from randomized controlled trials conducted in Japan and in the west.Treatment of painful diabetic neuropathyImpact of a stepwise protocol for treating pain on pain intensity in nursing home patients with dementia: a cluster randomized trial.EFNS guidelines on pharmacological treatment of neuropathic pain.Therapeutic management of chronic neuropathic pain: an examination of pharmacologic treatment.Quantitative sensory testing predicts pregabalin efficacy in painful chronic pancreatitis.Maintaining efficacy in the treatment of diabetic peripheral neuropathic pain: role of duloxetine
P2860
Q24239867-C7297511-6DDA-47B3-BA5A-17D1180A0272Q24632313-2A18D2A1-9861-4FD5-B28F-1EAF2E6A3407Q24657295-A482D278-7BDB-46F2-A5B3-2805C154A750Q24672126-712C4469-C09D-416B-A75C-D98833D2B95FQ26738297-FD537646-BC4D-4318-9E07-01E5512323DFQ26781422-29CA1E07-CB08-4301-A818-7CDDED333470Q28533906-56E6CC4F-FF88-41F4-9E38-D8104AA7157EQ28744504-24BF7D2C-04B2-4D9A-93A1-A37045D48766Q30537158-CEB4A17A-D201-40DB-982E-E258826820A0Q31170335-52169234-3C76-4D69-85BF-385A9437B3B1Q33369978-2638D1E1-8319-4798-950A-614FE9EE7BEDQ33393882-FFA9DFC7-9B0F-40A8-A2C8-1A79E232BDF3Q33408025-BA1860E2-4DF7-47F5-BC77-E5FCD935208DQ33554384-89EAA9EB-6211-49A5-BA80-0ED4C0EB34ECQ33554396-E375CCB3-A299-4085-BB08-1028571B20B0Q33583006-C1C30370-62F9-4E06-A747-A6F92DB6F16AQ33585572-8625942E-BC50-4971-BBA6-F3EE1CD39623Q33628834-130A7EA2-0A91-46E5-B083-9D975F12BA6EQ33739953-DD2A58A1-8645-4C8A-9457-9A814674DC64Q33747265-6DDF84E7-2706-464A-976D-3E86F6AEF8BFQ33798640-924C33FE-D580-4B61-8D7F-EC8705F457FCQ33855470-74E33169-D2FD-42A3-BD95-EAAA36FE2D46Q33870062-C6FC3E52-92B3-419C-8A2E-F1CDD954D79AQ33878023-10AA44DF-E87B-4695-8E04-E91BCE318878Q33880187-1B627B95-9C5D-46EA-9CD1-DB360388F57BQ33882897-96CB2C6A-CE3E-408A-BABB-0EE5C3D3F2B8Q33921692-14421634-F9AB-4627-9305-7397CBCA04A9Q33949565-B9CDA390-BCC5-4FB7-8F75-1B31BAB62829Q33953965-D5B86094-33E9-4C3D-AD37-5939C5FCAD78Q34038997-CBEDB49E-A44E-459C-9949-1DB1963F820BQ34180664-1B25A503-1CF4-4006-BE9B-8084175D3D83Q34183517-5DA2AC0A-7DE6-4A21-8978-658210253F8EQ34275990-EF30E020-6CBF-4A84-8D3B-8ACDB0E6E5FBQ34411257-A9E61464-F368-467E-BF22-7C81FB879B31Q34456265-CF90E631-4C97-48A7-A3C1-5A274DC5B91BQ34511242-EACCAEA0-AF24-4B2E-A1A3-91EEE02C1582Q34573607-19AFFE06-8507-4E4A-8AA9-6043F6AE4C28Q34595383-C2CED4C3-19EB-491A-9E22-DE5D93019C13Q34613361-04D9513C-8DA8-45C9-B220-500A744B1A82Q34620539-78CD4948-990E-493A-A73C-A75E17F1394D
P2860
Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Pregabalin for the treatment o ...... ind, placebo-controlled trial.
@en
Pregabalin for the treatment o ...... ind, placebo-controlled trial.
@nl
type
label
Pregabalin for the treatment o ...... ind, placebo-controlled trial.
@en
Pregabalin for the treatment o ...... ind, placebo-controlled trial.
@nl
prefLabel
Pregabalin for the treatment o ...... ind, placebo-controlled trial.
@en
Pregabalin for the treatment o ...... ind, placebo-controlled trial.
@nl
P2093
P1433
P1476
Pregabalin for the treatment o ...... ind, placebo-controlled trial.
@en
P2093
Linda LaMoreaux
Michael Tuchman
Uma Sharma
P304
P356
10.1016/J.PAIN.2004.05.001
P407
P577
2004-08-01T00:00:00Z